Serum Messenger RNA as a Biomarker and its Clinical Usefulness in Malignancies
A number of biomarkers are used clinically and many protein-based assay methods are available. Improvements in the method to utilize specific antibodies have led to remarkable progress in clinical diagnosis using biomarkers. Proteomics studies to identify better biomarkers have been performed worldw...
Main Authors: | Norimasa Miura, Junichi Hasegawa, Goshi Shiota |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2008-01-01
|
Series: | Clinical Medicine Insights: Oncology |
Online Access: | https://doi.org/10.4137/CMO.S379 |
Similar Items
-
Prognostic impact of clinical course-specific mRNA expression profiles in the serum of perioperative patients with esophageal cancer in the ICU: a case control study
by: Oshima Yoshiaki, et al.
Published: (2010-10-01) -
A novel biomarker TERTmRNA is applicable for early detection of hepatoma
by: Hirooka Yasuaki, et al.
Published: (2010-05-01) -
Messenger RNA in chlorella
by: Lambe, C. A.
Published: (1977) -
Discovery of plasma messenger RNA as novel biomarker for gastric cancer identified through bioinformatics analysis and clinical validation
by: Wei Cao, et al.
Published: (2019-06-01) -
Comparison of circulating, hepatocyte specific messenger RNA and microRNA as biomarkers for chronic hepatitis B and C.
by: Xiaonan Zhang, et al.
Published: (2014-01-01)